Phosphoinositide-specific phospholipase C (PLC) is a key enzyme in phosphoinositide turnover and is involved in a variety of physiological functions. We analyzed PLC␦1 knockout mice and found that PLC␦1 is required for the maintenance of skin homeostasis. However, there were no remarkable abnormalities except hair loss and runting in PLC␦1 knockout mice, even though PLC␦1 is broadly distributed. Here, we report that mice lacking both PLC␦1 and PLC␦3 died at embryonic day 11.5 (E11.5) to E13.5. PLC␦1/PLC␦3 doubleknockout mice exhibited severe disruption of the normal labyrinth architecture in the placenta and decreased placental vascularization, as well as abnormal proliferation and apoptosis of trophoblasts in the labyrinth area. Furthermore, PLC␦1/PLC␦3 double-knockout embryos supplied with a normal placenta by the tetraploid aggregation method survived beyond E14.5, clearly indicating that the embryonic lethality is caused by a defect in trophoblasts. On the basis of these results, we conclude that PLC␦1 and PLC␦3 are essential in trophoblasts for placental development.
Phosphoinositide-specific phospholipase C (PLC) hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate two second messengers, diacylglycerol and inositol 1,4,5-trisphosphate. Diacylglycerol mediates the activation of protein kinase C, and inositol 1,4,5-trisphosphate releases calcium from intracellular stores (1, 19) .
PLC can be categorized into six types, ␤, ␥, ␦, ε, , and , on the basis of sequence homology and activation mechanism (5, 13, 20, 21, 23, 24, 34) . Each isozyme is composed of subtypespecific and conserved domains. All PLC isozymes contain catalytic X and Y domains, as well as various regulatory domains, including the C2 domain, EF-hand motif, and pleckstrin homology domain. Subtype-specific domains contribute to the specific regulatory mechanisms. These domains include the src homology domain in PLC␥ (23) and the Ras-associating domain and Ras-GTPase exchange factor-like domain in PLCε (15, 29) .
PLC␦ types are evolutionarily conserved from lower to higher eukaryotes, and these isozymes are thought to be the primary forms expressed in mammals. Therefore, PLC␦ is expected to have important and basic physiological functions. There are three PLC␦ isozymes, PLC␦1, -␦3, and -␦4 (10) . It has been suggested that PLC␦1 is involved in Alzheimer's disease (27) and essential hypertension (14, 35) . Recently, we analyzed PLC␦ knockout (KO) mice and found that PLC␦1 has an important role in skin homeostasis (18) and that PLC␦4 is involved in the acrosome reaction of sperm (6, 7) . These results provide some clarification of the physiological functions of PLC␦1 and PLC␦4; however, the function of PLC␦3 remains unknown.
In the present study, to elucidate the physiological roles of PLC␦3, we analyzed PLC␦3 KO mice. Thus far, PLC␦3 KO mice have exhibited no obvious abnormalities. Because PLC␦3 is most similar to PLC␦1, we generated mice lacking both PLC␦1 and PLC␦3 genes (PLC␦1/PLC␦3 double-knockout [DKO] mice). We found that simultaneous disruption of PLC␦1 and PLC␦3 resulted in embryonic lethality at midgestation. In PLC␦1/PLC␦3 DKO mice, the structure of the placental labyrinth layer was abnormal, and placental vascularization was decreased. Furthermore, tetraploid (4N) aggregation experiments revealed that the primary cause of embryonic lethality is a trophoblast defect. Thus, PLC␦1 and PLC␦3 play important roles in normal development of the placenta.
MATERIALS AND METHODS

Generation of PLC␦3 KO mice. PLC␦3 heterozygous (PLC␦3
ϩ/Ϫ ) mice were generated by Lexicon Genetics Incorporated (The Woodlands, TX) from Omni Bank clone OST101546 as described previously (37) . Once germ line transmission had been validated by PCR, the PLC␦3 ϩ/Ϫ animals were mated with an animal with a C57BL/6J background, resulting in a 129Sv/lex ϫ C57BL/6J hybrid background.
Mouse breeding to generate PLC␦1/PLC␦3 DKO mice. PLC␦1 KO strains have been described previously (18) . To generate PLC␦1/PLC␦3 DKO mice, the PLC␦1 and PLC␦3 KO mouse lines were interbred. Mouse tail tips, small parts of yolk sacs, or embryos were used for genotyping by PCR. Primers for PCR analysis of PLC␦1 were described previously (18) . Primers for PLC␦3 were 5Ј-TTAACCTGATGCTCCTGAGG-3Ј, 5Ј-GGATAAAATGCTTGCCCTGC-3Ј, and 5Ј-AAAATGGCGTTACTTAAGCTTGC-3Ј. Gene targeting was also verified by Western blot analysis with appropriate antibodies.
Antibodies and Western blot analysis. Mouse monoclonal antibodies against PLC␦3 were developed by immunizing PLC␦3 KO mice with full-length mouse PLC␦3 protein as an antigen. PLC␦1 polyclonal antibody was a gift from PannGhill Suh (POSTECH, Korea). Anti-␤-actin antibody was purchased from Chemicon (Temecula, CA). Various tissues or cells for Western blot analysis were homogenized with a buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100), sonicated, and centrifuged for 15 min at 13,000 ϫ g to remove insoluble debris. Sodium dodecyl sulfate (SDS) sample buffer was then added, and the mixture was incubated for 5 min at 95°C. The lysates were resolved by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes, and probed with antibodies as described previously (17) .
Histochemistry and immunohistochemistry. For histological analyses, placentas were fixed in 4% paraformaldehyde or 2% glutaraldehyde, dehydrated, and embedded in paraffin. Sections (5 m) were stained with hematoxylin and eosin (HE). For PLC␦1 immunohistochemistry, placentas were fixed overnight in 4% paraformaldehyde at 4°C and embedded in paraffin. Paraffin sections (5 m) were prepared. These sections were boiled in a microwave oven in 10 mM sodium citrate buffer (pH 6.0) for antigen retrieval and incubated with rabbit polyclonal anti-PLC␦1 antibody, followed by the procedure described in the technical bulletin of the tyramide signal amplification immunodetection kit (Perkin-Elmer, Boston, MA). Whole-mount CD31 staining of embryonal heads and yolk sacs was performed as described previously (36) .
TUNEL assay and BrdU labeling. Terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling (TUNEL) assays were performed with an ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (CHEMICON) according to the manufacturer's recommendations. bromodeoxyuridine (BrdU) labeling was performed with a 5-Bromo-2Ј-Deoxyuridine Labeling and Detection Kit II (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's recommendations by intraperitoneal injection of BrdU into pregnant mice.
Electron microscopy. Placentas were fixed with 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3). Specimens were postfixed with 2% osmium tetroxide for 2 h, block stained with 3% uranyl acetate for 2 h, and embedded in epoxy resin. Thin sections were cut, stained with uranyl acetate and lead citrate, and examined with a Hitachi H-800 transmission electron microscope.
Tetraploid chimera experiment. Two-cell-stage embryos were obtained from the oviducts of B6C3F1 females at embryonic day 1.5 (E1.5). The two-cell-stage embryos were placed in 0.3 M mannitol and aligned in a 5-V AC field and fused with two 40-s 150-V DC pulses from a 1-mm electrode and a BTX Electro Cell Manipulator 2001 electrofusion apparatus (BTX, San Diego, CA). Fused embryos were cultured overnight. The zona was removed, and four-or eight-cellstage diploid (2N) embryos derived from PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/Ϫ intercross matings were aggregated with four-cell-stage 4N B6C3F1 embryos. Chimeric embryos that developed successfully into blastocysts were transferred to the uterus of a pseudopregnant female.
RESULTS
Generation of PLC␦3 KO and PLC␦1/PLC␦3 DKO mice. To date, KO mice for many PLC isozymes have been generated and analyzed (5) . Interestingly, these KO mice displayed distinct phenotypes, suggesting that although there are as many as 13 PLC isozymes, each has unique physiological functions. Therefore, we attempted to elucidate the physiological functions of PLC␦3 by generating and analyzing PLC␦3 KO mice. We first searched the Omni Bank embryonic stem (ES) cell library (Lexicon Genetics Incorporated) and identified one ES cell clone (OST101546) that had a retroviral gene trap insertion between exon 1, which contains the translation initiation codon, and exon 2 of the PLC␦3 mRNA. ES cell clone OST101546 was used to generate the PLC␦3 KO mice (Fig. 1A) . Disruption of PLC␦3 was confirmed by PCR analysis of genomic DNA (Fig. 1B) and Western blot analysis of protein from the heart (Fig. 1C) . PLC␦3 KO mice were viable, fertile, and apparently normal (Fig. 1D) . Western blot analysis revealed that the tissue distribution of PLC␦3 overlaps that of PLC␦1 (Fig. 1E) , which shares high homology with PLC␦3 (Fig. 1F) , suggesting that the two genes may be functionally redundant. To investigate this possibility, we next generated PLC␦1/PLC␦3 DKO mice (Fig. 1G) To determine the time of embryonic lethality, embryos at various stages of gestation were isolated. By E10.5, PLC␦1/ PLC␦3 DKO embryos were detected at the expected Mendelian frequency (Table 1 ) and were indistinguishable from PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ littermates. However, by E11.5, 43% of PLC␦1/PLC␦3 DKO embryos were dead or abnormal, and the proportion of dead or abnormal embryos had increased to 56% by E12.5. By E13.5, all PLC␦1/PLC␦3 DKO embryos were dead or visibly abnormal. At E11.5, most living PLC␦1/PLC␦3 DKO embryos appeared normal ( Fig. 2A and B) , but the hearts of some PLC␦1/PLC␦3 DKO embryos had stopped beating. At E12.5, the body sizes of PLC␦1/PLC␦3 DKO embryos were smaller than those of PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ embryos, and hemorrhages in the cardiac and ventral body wall regions were visible in some PLC␦1/PLC␦3 DKO embryos (Fig. 2D ). In addition, the yolk sacs of PLC␦1/PLC␦3 DKO mice appeared pale, with few vessels and blood cells ( Fig. 2E and F). These observations indicate that PLC␦1 and PLC␦3 are required for normal embryonic development.
Vascular defects in PLC␦1/PLC␦3 DKO embryos. The vascular system undergoes significant development during midgestation, which is the time when PLC␦1/PLC␦3 DKO embryos die. Therefore, we investigated the development of the vascular system in PLC␦1/PLC␦3 DKO embryos. Development of the embryonic vascular system involves two distinct processes: vasculogenesis and angiogenesis. During vasculogenesis, angioblasts are committed to an endothelial cell fate and form the primitive vascular plexus. The endothelial cells in the primitive vascular plexus then proliferate, migrate, and form complex vascular networks that contain vessels with various diameters and many branches in a process known as angiogenesis. In PLC␦1/ PLC␦3 DKO embryos, vasculogenesis occurred normally (data not shown); however, some defects in angiogenesis were observed. At E12.5, vascular remodeling into small and large vessels had occurred in the head region of PLC␦1
PLC␦3
ϩ/ϩ embryos ( Fig. 2G) , whereas large-diameter vessels, which appeared to be irregularly shaped, were observed in the head region of PLC␦1/PLC␦3 DKO embryos (Fig. 2H ). In addition, yolk sacs of E12.5 PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ embryos contained a complex vascular network that was composed of large-and small-diameter vessels (Fig. 2I ), whereas yolk sacs from PLC␦1/PLC␦3 DKO embryos contained a relatively simple vascular network that consisted of equal-diameter vessels (Fig. 2J) .
Thus, angiogenic remodeling did not occur normally in PLC␦1/PLC␦3 DKO embryos. However, these vascular defects were observed only in embryos that were obviously abnormal or already dead. Therefore, we speculated that there was another defect that contributed to embryonic lethality in PLC␦1/ PLC␦3 DKO embryos.
Abundant expression of PLC␦1 and PLC␦3 in placenta.
Around E11.5 to E13.5, placental defects are one of the main causes of embryonic lethality. Therefore, we examined expression of PLC␦1 and PLC␦3 in various tissues, including the placenta. Western blotting of tissues from E11.5 embryos revealed that both PLC␦1 and PLC␦3 exist most abundantly in the placenta (Fig. 3A) . We confirmed that PLC␦1 levels were comparable between maternal decidual tissue and the embryonic origin of the placenta, whereas PLC␦3 was expressed more abundantly in the maternal part, but a significant level of PLC␦3 protein was still detected in the embryonic part (Fig. 3B) . The embryonic portion of the placenta is composed mainly of trophoblasts. Therefore, we examined the expression of PLC␦1 and PLC␦3 in trophoblast stem (TS) cells, which differentiate into giant trophoblasts by depleting culture medium of fibroblast growth factor (30) . PLC␦1 and PLC␦3 levels in lysates of TS cells were significantly higher than those of mouse embryonic fibroblasts, although the levels of PLC␦1 and PLC␦3 did not change during differentiation of TS cells (Fig. 3C) . Furthermore, we carried out immunohistochemical analysis. Immunohistochemical analysis with anti-PLC␦1 antibody showed that PLC␦1 was expressed abundantly in trophoblasts of wildtype placentas ( Fig. 3D and F) , although PLC␦3 expression could not be detected because of the unavailability of our anti-PLC␦3 antibody for immunohistochemical analysis (data not shown). We also confirmed that PLC␦1 immunoreactivity was not detected in placentas of PLC␦1 KO mice (Fig. 3E) , indicating that the signal is specific. These data indicate that PLC␦1 and PLC␦3 are expressed at high levels in trophoblasts of the placenta. Reduced vascularization of the labyrinth area in PLC␦1/ PLC␦3 DKO placenta. Because PLC␦1 and PLC␦3 are expressed at high levels in the placenta, we analyzed morphological changes in placentas from PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO embryos by HE staining. The embryonic part of the placenta is composed of three distinct trophoblast cell layers, the labyrinth layer, the spongiotrophoblast layer, and the giant trophoblast layer, moving from the embryo side to the maternal side (28) . The labyrinth layer contains a large number of maternal and embryonic vessels and is the site of oxygen, nutrient, and waste exchange between the mother and the embryo. At E10.5, the structures of the labyrinth layers in PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas were indistinguishable. The numbers of embryonic and maternal vessels were also similar (Fig. 4A to D) . At this stage, embryonic vessels (Fig. 4C and D) in the labyrinth area could be discriminated from maternal vessels (Fig. 4C and D) on the basis of differences in hemocyte morphology. However, at E11.5, we observed a remarkable difference in the labyrinth structure between PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas. The labyrinth layer of PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ placentas contained many maternal and embryonic vessels ( Fig. 4E and G) , whereas the numbers of these vessels in the labyrinth layer of PLC␦1/PLC␦3 DKO placentas were severely reduced ( Fig. 4F and H) . We also noticed that the labyrinth layer of PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ placentas was reddish, whereas the color of PLC␦1/PLC␦3 DKO placentas was somewhat yellowish (data not shown), suggesting reduced vascularization. These abnormalities were already observed in apparently normal PLC␦1/PLC␦3 DKO embryos at E11.5. When we calculated the ratio of the vascularized area to the total labyrinth area using NIH Image software, the ratio in PLC␦1/PLC␦3 DKO placentas was much lower (0.15 Ϯ 0.038) than that in PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ placentas (0.27 Ϯ 0.035) (Fig. 4I) . The ratios of the vascularized area to the total labyrinth area were comparable in PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas at E10.5, suggesting that the abnormal morphological changes in the PLC␦1/PLC␦3 DKO placenta occur between E10.5 and E11.5. These abnormalities lead to insufficient exchange of gas, nutrients, and waste and therefore are likely to cause the midgestational embryonic lethality of PLC␦1/PLC␦3 DKO mice. Reduced proliferation and aberrant apoptosis in cells of PLC␦1/PLC␦3 DKO labyrinth area. The developmental defect in the labyrinth area of PLC␦1/PLC␦3 DKO mice suggests that proliferation of cells in this area is abnormal. Therefore, we examined the proliferative activity of cells in the labyrinth layer using BrdU incorporation. At E11.5, the PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ labyrinth layer contained many BrdU-positive cells ( Fig. 5A and C). In contrast, the PLC␦1/PLC␦3 DKO labyrinth area displayed low BrdU incorporation ( Fig. 5B and D) . We also found that the labyrinth layer of the PLC␦1/PLC␦3 DKO placenta contained necrotic or apoptotic cells (Fig. 5E ). Therefore, we next analyzed apoptosis in sections of the placenta using the TUNEL technique. Few or no TUNEL-positive cells were observed in the labyrinth layer of PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ placentas ( Fig. 5F ), whereas many TUNEL-positive cells were present in the labyrinth layer of PLC␦1/PLC␦3 DKO placentas ( Fig. 5G and H) . The necrotic or apoptotic cells exhibited an elongated morphology and were similar to syncytiotrophoblasts, which are located between a layer of mononuclear trophoblasts that line the maternal sinusoids and fetal endothelial cells and play a critical role in nutrient transport (28) . We then performed ultrastructural analysis of cells in the labyrinth layer of PLC␦1/PLC␦3 DKO mice to identify dead cells and confirm the presence of features associated with apoptosis. In the PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ placenta, we observed endothelial cells, syncytiotrophoblasts, and mononucleated trophoblasts, which have intact cellular structure, between the embryonic vessels and maternal vessels (Fig. 5I) . In contrast, vacuolation of nuclei (Fig. 5J , K, L, and M) and trophoblast fragmentation (Fig. 5J, K , N, O, and P) were observed in the labyrinth area of PLC␦1/ PLC␦3 DKO placentas. Such trophoblast fragmentation and nuclear vacuolation were never observed in PLC␦1
PLC␦3
ϩ/ϩ placentas (Fig. 5I ). In addition, endothelial cells of PLC␦1/PLC␦3 DKO placentas appeared normal even when the surrounding trophoblasts had died (Fig. 5J, K , O, and P), indicating that apoptosis of PLC␦1/PLC␦3 DKO trophoblasts is a primary phenomenon. Furthermore, electron microscopy revealed that the dead cells were positioned mainly just outside of embryonic endothelial cells (Fig. 5J, K , O, and P), indicating that the dead cells in PLC␦1/PLC␦3 DKO placentas were syncytiotrophoblasts. These results were consistent with those of HE (Fig. 5E ) and TUNEL staining (Fig. 5H ) and suggest that PLC␦1 and PLC␦3 influence the survival and proliferation of trophoblasts in the labyrinth layer of the placenta.
Rescue of PLC␦1/PLC␦3 DKO embryos from embryonic lethality by supplying wild-type placenta. Because PLC␦1/PLC␦3 DKO embryos show vascular defects (Fig. 2G to J) , as well as placental trophoblast defects, we attempted to examine whether the primary cause of embryonic lethality of PLC␦1/ PLC␦3 DKO mice is the placental trophoblast defect. We aggregated wild-type 4N embryos with 2N embryos derived from PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/Ϫ intercrosses. In this case, the wildtype 4N cells contributed exclusively to the placental trophoblast cells and endoderm of the yolk sac, whereas the 2N cells contributed mainly to the embryo proper (12) (Fig. 6A) . Thus, if the embryonic lethality of PLC␦1/PLC␦3 DKO mice is due only to a placental trophoblast defect, PLC␦1/PLC␦3 DKO embryos with wild-type placentas should survive beyond E13.5, the time when all PLC␦1/PLC␦3 DKO embryos were dead or abnormal. With this method, we detected 2 living PLC␦1/ PLC␦3 DKO embryos among 16 embryos at E14.5 ( Fig. 6B to  D) . We also examined the morphology of the placentas of PLC␦1/PLC␦3 DKO mice rescued by tetraploid aggregation. In contrast to the labyrinth area of the PLC␦1/PLC␦3 DKO placenta ( Fig. 4F and H) , the placentas of rescued PLC␦1/ PLC␦3 DKO embryos contained many maternal and embryonic vessels, although the ratio of the vascularized area to the total labyrinth area in rescued PLC␦1/PLC␦3 DKO placentas was slightly lower than that of control placentas (Fig. 6E to G) . These results clearly indicate that the embryonic lethality observed in PLC␦1/PLC␦3 DKO mice is caused primarily and mainly by trophoblast defects.
DISCUSSION
In the present study, we attempted to elucidate the physiological functions of PLC␦3 by analyzing PLC␦3 KO mice (Fig. 1A to  C) . PLC␦3 KO mice appeared normal (Fig. 1D) ; however, we cannot rule out the possibility that functional abnormalities are present in some organs or systems of PLC␦3 KO mice. PLC␦3 has the highest sequence homology to PLC␦1, and the proteins have similar tissue distribution patterns ( Fig. 1E and F) . In addition, PLC␦1 KO mice showed no obvious abnormalities, except for disturbance of skin homeostasis and runting (18) . These facts suggest that PLC␦1 and PLC␦3 are functionally redundant and that the phenotypes were masked in single-gene KO mice. Therefore, we generated PLC␦1/␦3 DKO mice and found that these mice died in midgestation ( Table 1) . The primary cause of embryonic lethality was defective development of the placenta. The placenta is composed of the maternal decidual tissue and a fetal portion that consists of three distinct trophoblast cell layers. Among these layers, the labyrinth layer contains many maternal and fetal vessels and plays a critical role in the exchange of nutrients and gas between the mother and the embryo. Therefore, normal placental function is essential for development of the embryo. We found that the labyrinth layer of PLC␦1/PLC␦3 DKO placentas contains fewer maternal and embryonic vessels ( Fig. 4F and  H) . In addition, trophoblasts of the labyrinth layer of PLC␦1/ PLC␦3 DKO placentas displayed aberrant cell death (Fig. 5E , G, and H). Cell death of some endothelial cells was also observed. However, electron microscopy revealed that trophoblasts died earlier than endothelial cells (Fig. 5J, K , O, and P). Therefore, a trophoblast abnormality was the primary cause of aberrant cell death and reduced proliferation of cells (Fig. 5B  and D) in the placental labyrinth area, and death of endothelial cells may be a secondary effect of the death of surrounding trophoblasts. Because trophoblasts secrete several angiogenic factors, which play important roles in the growth and survival of endothelial cells and trophoblasts (38) , it is possible that PLC␦1/PLC␦3 DKO trophoblasts secret insufficient angiogenic factors, which leads to reduced vascularization in PLC␦1/ PLC␦3 DKO placentas. Therefore, we examined the expression levels of angiogenic factors, such as vascular endothelial growth factor (VEGF), placenta growth factor (PlGF), angiopoietin 1, and angiopoietin 2 in E11. ences in the expression levels of these genes between PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas (data not shown). We also found that the labyrinth structures were normal and that many fetal and maternal vessels were present in PLC␦1/PLC␦3 DKO placentas at E10.5 ( Fig. 4B and D) . This suggests that chorioallantoic fusion and branching occurred normally and that the fetal and maternal vessels in the labyrinth area are formed at this stage. Therefore, PLC␦1 and PLC␦3 may not be essential for morphogenesis of the labyrinth area by E10.5 but may be required for the survival of trophoblasts and maintenance of normal labyrinth structure at later stages.
The labyrinth area contains several distinct subtypes of trophoblasts that are present in specific locations, and these cell types can be readily distinguished on the basis of their positions and morphologies (28, 32) . HE staining, TUNEL staining, and electron microscopy revealed that placental defects in PLC␦1/PLC␦3 DKO mice were due mainly to a syncytiotrophoblast abnormality (Fig. 5E , H, K, and O). Syncytiotrophoblast formation is a unique process that involves cell cycle exit and then fusion of these cells to form a syncytium (28) . However, very little is known about the mechanism that underlies fusion of mouse trophoblasts. We investigated the expression levels of syncytins, which was reported to play the critical role in syncytiotrophoblast formation (2, 16) , in E11.5 PLC␦1
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ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas by reverse transcription-PCR analysis and found that there were no remarkable differences in the expression levels of syncytin between PLC␦1 Ϫ/Ϫ PLC␦3 ϩ/ϩ and PLC␦1/PLC␦3 DKO placentas (data not shown). Syncytiotrophoblasts play critical roles in normal placental function and embryo development. Exchange of nutrients and waste in the labyrinth area is dependent on syncytiotrophoblast functions, including endocytosis, exocytosis, and transcytosis (4). Phosphoinositide metabolism has been reported to be involved in membrane fusion or trafficking events, such as clathrin-mediated internalization of receptors or exocytosis of neurotransmitters (11, 33) . Therefore, phosphoinositide metabolism may play important roles in the formation and function of syncytiotrophoblasts, and disturbance of phosphoinositide metabolism by deletion of the PLC␦1 and PLC␦3 genes may lead to syncytiotrophoblast abnormalities.
Because some dead or abnormal PLC␦1/PLC␦3 DKO embryos show vascular defects (Fig. 2G to J) in addition to placental defects, we used the tetraploid aggregation technique (Fig. 6A) to clarify placental trophoblast defects. The embryonic lethality by E13.5 was rescued by this method (Fig. 6B to  F) , indicating clearly that trophoblast abnormalities cause lethality of PLC␦1/PLC␦3 DKO embryos at this stage. However, the defect in vascularization of the labyrinth area of rescued PLC␦1/PLC␦3 DKO mice was not completely rescued, although a drastic improvement in vascularization was observed (Fig. 6G) . It has been reported that wild-type 4N cells contribute exclusively to placental trophoblasts and endoderm of the yolk sac, whereas PLC␦1/PLC␦3 DKO 2N cells contribute to the embryo proper. However, some populations of 2N cells contribute partially to placental trophoblasts, resulting in a placenta that is a chimera of 4N and 2N cells (12) . Therefore, the labyrinth area of rescued PLC␦1/PLC␦3 DKO embryos may contain a few 2N PLC␦1/PLC␦3 DKO trophoblasts, and these PLC␦1/PLC␦3 DKO trophoblasts may inhibit complete rescue of vascularization in aggregation experiments.
To date, many genes, including those for transcription factors, growth factors/receptors, and other signal transduction molecules, have been reported to be involved in the development of the placental labyrinth layer (32) . However, the molecules upstream and downstream in signaling pathways involving these genes are not fully understood. The results of the present study indicate that PLC␦1 and PLC␦3 must also be considered in placental development. Because PLC activation induces elevation of intracellular calcium levels and protein kinase C activation, leading to modulation of various downstream molecules, it will be very interesting to clarify how PLC␦1 and PLC␦3 affect placental development. One signal transduction pathway that is involved in placental morphogenesis is Rho signaling. It was recently reported that the deleted in liver cancer 1 (DLC-1) gene, a Rho GTPase-activating protein, and the rho-associated kinase 2 (ROCKII) gene are essential for placental labyrinth layer development (3, 31) . Because DLC-1 binds directly to PLC␦1 to activate PLC␦1 enzyme activity (9, 26) and because RhoA inhibits PLC␦1 enzyme activity (8) , Rho signaling may modulate PLC␦1 activity during placental development. Together, we show here for the first time that PLC␦1 and PLC␦3 are required for normal morphogenesis and function of the placenta in mice. Although the gross anatomy and physiology of the mouse and human placentas are different, they share considerable cellular and molecular characteristics (25) . In addition, intrauterine growth retardation with labyrinth vascular defects has been observed in human preeclampsia and missed abortion (22) . Therefore, it is very important to elucidate whether PLC␦1 and PLC␦3 play similar roles in the human placenta, and understanding the signaling pathways that involve PLC␦1 and PLC␦3 may clarify the events in the process of placentogenesis and contribute to the development of treatments for missed abortion and preeclampsia.
